Suchergebnisse

Dr. Angela Y. Davis is a political activist, academician, and writer who has navigated and discussed issues of race, class, gender, and USA social policies across her 75 years of life. Davis's activism established her as the icon of a larger social movement and further related to her decision-making and legacy. Using psychobiographical methods, data were gathered through publicly available sources to explore Davis's personal, professional, and representational life, as well as understand Davis's lived experience through a socio-cultural-historical perspective. Two established theories, Social Cognitive Career Theory and Politicized Collective Identity model, were applied to Davis's life. Findings suggested that in addition to her unique intersectional identities, a confluence of factors including growing up in a family of activists, incarceration, Federal Bureau of Investigation (FBI) surveillance, Communist Party involvement, marginalization within activist spaces, and practicing radical self-care impacted Davis committing to a life as an activist, academic, and the leader of a social movement.

Dr. Angela Y. Davis is a political activist, academician, and writer who has navigated and discussed issues of race, class, gender, and USA social policies across her 75 years of life. Davis's activism established her as the icon of a larger social movement and further related to her decision-making and legacy. Using psychobiographical methods, data were gathered through publicly available sources to explore Davis's personal, professional, and representational life, as well as understand Davis's lived experience through a socio-cultural-historical perspective. Two established theories, Social Cognitive Career Theory and Politicized Collective Identity model, were applied to Davis's life. Findings suggested that in addition to her unique intersectional identities, a confluence of factors including growing up in a family of activists, incarceration, Federal Bureau of Investigation (FBI) surveillance, Communist Party involvement, marginalization within activist spaces, and practicing radical self-care impacted Davis committing to a life as an activist, academic, and the leader of a social movement. ; peerReviewed ; publishedVersion

Objectives: The INCAPS COVID Oceania study aimed to assess the impact caused by the COVID-19 pandemic on cardiac procedure volume provided in the Oceania region. Methods: A retrospective survey was performed comparing procedure volumes within March 2019 (pre-COVID-19) with April 2020 (during first wave of COVID-19 pandemic). Sixty-three (63) health care facilities within Oceania that perform cardiac diagnostic procedures were surveyed, including a mixture of metropolitan and regional, hospital and outpatient, public and private sites, and 846 facilities outside of Oceania. The percentage change in procedure volume was measured between March 2019 and April 2020, compared by test type and by facility. Results: In Oceania, the total cardiac diagnostic procedure volume was reduced by 52.2% from March 2019 to April 2020, compared to a reduction of 75.9% seen in the rest of the world (p<0.001). Within Oceania sites, this reduction varied significantly between procedure types, but not between types of health care facility. All procedure types (other than stress cardiac magnetic resonance [CMR] and positron emission tomography [PET]) saw significant reductions in volume over this time period (p<0.001). In Oceania, transthoracic echocardiography (TTE) decreased by 51.6%, transoesophageal echocardiography (TOE) by 74.0%, and stress tests by 65% overall, which was more pronounced for stress electrocardiograph (ECG) (81.8%) and stress echocardiography (76.7%) compared to stress single-photon emission computerised tomography (SPECT) (44.3%). Invasive coronary angiography decreased by 36.7% in Oceania. Conclusion: A significant reduction in cardiac diagnostic procedure volume was seen across all facility types in Oceania and was likely a function of recommendations from cardiac societies and directives from government to minimise spread of COVID-19 amongst patients and staff. Longer term evaluation is important to assess for negative patient outcomes which may relate to deferral of usual models of care within cardiology.